Dang Ashujot Kaur, Gonzalez Daniel A, Kumar Rajeswar, Asif Saba, Bali Anoushka, Anne Krishna Kishore, Konanur Srinivasa Nithin Kumar
Research, Government Medical College, Patiala, Patiala, IND.
General Physician, Universidad Catolica Santiago de Guayaquil, Guayaquil, ECU.
Cureus. 2022 Jun 21;14(6):e26144. doi: 10.7759/cureus.26144. eCollection 2022 Jun.
Inflammatory bowel disease (IBD), comprising of ulcerative colitis (UC) and Crohn's disease (CrD), is a chronic relapsing-remitting inflammation of the bowel with extraintestinal involvement. Numerous studies published in the last decade have underlined the dangerous cardiovascular disease (CVD) outcomes of IBD, such as ischemic heart disease, heart failure, and stroke, and the need for better therapeutic and prognostic strategies. This article elucidated the pathological web of mechanisms that link IBD with CVD, such as immune dysregulation, endothelial dysfunction, arterial stiffness, and dysbiosis, with a comprehensive review of clinical studies standing for and against the notion in pediatric and adult populations. The current treatment and prevention aim at disease remission and dietary strategies shown to reduce the CVD risk. Exploration of other supplemental preventive and treatment methods, especially during active flares of disease, to reduce the risk of arterial thromboembolic disease (ATED) is the need of the hour.
炎症性肠病(IBD)包括溃疡性结肠炎(UC)和克罗恩病(CrD),是一种伴有肠外表现的慢性复发性肠道炎症。过去十年发表的众多研究强调了IBD患者发生危险心血管疾病(CVD)的后果,如缺血性心脏病、心力衰竭和中风,以及制定更好的治疗和预后策略的必要性。本文阐述了将IBD与CVD联系起来的病理机制网络,如免疫失调、内皮功能障碍、动脉僵硬和肠道菌群失调,并全面回顾了支持和反对该观点的儿科和成人临床研究。目前的治疗和预防旨在实现疾病缓解以及采用已证明可降低CVD风险的饮食策略。当下迫切需要探索其他补充性预防和治疗方法,尤其是在疾病活动期,以降低动脉血栓栓塞性疾病(ATED)的风险。